Mental disorders
US5817656A · kind A · utility
42Cited by
6References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1996 |
| Grant date | Oct 6, 1998 |
| Priority date | — |
| Expiry date | Nov 13, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-2,3-b!1,5!benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of mental disorders. The compound has the following structure: ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.